{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:16:50Z","timestamp":1790237810907,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01DK107405"],"award-info":[{"award-number":["R01DK107405"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["U01GM116196"],"award-info":[{"award-number":["U01GM116196"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["RO1 HL128237"],"award-info":[{"award-number":["RO1 HL128237"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bvth.2024.100015","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T01:42:30Z","timestamp":1718674950000},"page":"100015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeting the P-selectin\/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-0036","authenticated-orcid":false,"given":"Samira","family":"Escopy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-4571","authenticated-orcid":false,"given":"Elliot L.","family":"Chaikof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0092-8674(89)90636-3","article-title":"Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation","volume":"56","author":"Johnston","year":"1989","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bvth.2024.100015_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/14728222.11.8.1103","article-title":"P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis","volume":"11","author":"Ludwig","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bvth.2024.100015_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00294","article-title":"Platelets and their chemokines in atherosclerosis\u2014clinical applications","volume":"5","author":"von Hundelshausen","year":"2014","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1160\/TH04-05-0306","article-title":"Role of P-selectin and PSGL-1 in coagulation and thrombosis","volume":"92","author":"Vandendries","year":"2004","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12032-023-02207-2","article-title":"The roles of P-selectin in cancer cachexia","volume":"40","author":"Ling","year":"2023","journal-title":"Med Oncol"},{"issue":"19","key":"10.1016\/j.bvth.2024.100015_bib6","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1182\/blood.2021011151","article-title":"P-selectin and sickle cell disease: a balancing act","volume":"137","author":"Manwani","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bvth.2024.100015_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy","volume":"22","author":"Conway","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bvth.2024.100015_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","volume":"14","author":"Maneta","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2024.04.008","article-title":"Platelets: orchestrators of immunity in host defense and beyond","volume":"57","author":"Nicolai","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102344","article-title":"Immunothrombosis versus thrombo-inflammation: platelets in cerebrovascular complications","volume":"8","author":"Li","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/ATVBAHA.122.317162","article-title":"Thromboinflammation: from atherosclerosis to COVID-19","volume":"42","author":"Wagner","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib14","first-page":"899","article-title":"P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism","volume":"99","author":"Ay","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1160\/TH06-12-0730","article-title":"The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154","volume":"97","author":"Bugert","year":"2007","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.bvth.2024.100015_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/ATVBAHA.108.169532","article-title":"Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the coronary artery risk development in young adults (CARDIA) study","volume":"28","author":"Reiner","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1538-7836.2008.02952.x","article-title":"P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study","volume":"6","author":"Marteau","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1538-7836.2007.02805.x","article-title":"Clinical and genetic correlates of soluble P-selectin in the community","volume":"6","author":"Lee","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13045-021-01136-9","article-title":"SELP Asp603Asn and severe thrombosis in COVID-19 males","volume":"14","author":"Fallerini","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib20","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.atherosclerosis.2007.03.007","article-title":"Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes\/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"195","author":"Volcik","year":"2007","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib21","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1373\/clinchem.2008.119487","article-title":"SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study","volume":"55","author":"Volcik","year":"2009","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1083\/jcb.118.2.445","article-title":"Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells","volume":"118","author":"Moore","year":"1992","journal-title":"J\u00a0Cell Biol"},{"issue":"17","key":"10.1016\/j.bvth.2024.100015_bib24","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1016\/S0021-9258(18)31454-6","article-title":"Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides","volume":"268","author":"Norgard","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(93)90327-M","article-title":"Expression cloning of a functional glycoprotein ligand for P-selectin","volume":"75","author":"Sako","year":"1993","journal-title":"Cell"},{"issue":"37","key":"10.1016\/j.bvth.2024.100015_bib26","doi-asserted-by":"crossref","first-page":"23318","DOI":"10.1016\/S0021-9258(17)31656-3","article-title":"The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine","volume":"269","author":"Moore","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90173-6","article-title":"A\u00a0sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding","volume":"83","author":"Sako","year":"1995","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.bvth.2024.100015_bib28","doi-asserted-by":"crossref","first-page":"39569","DOI":"10.1074\/jbc.M005005200","article-title":"Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues","volume":"275","author":"Lepp\u00e4nen","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(00)00138-0","article-title":"Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P-and E-selectin bound to SLeX and PSGL-1","volume":"103","author":"Somers","year":"2000","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bvth.2024.100015_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/ja9610702","article-title":"Conformation of sLex tetrasaccharide, free in solution and bound to E-P-and L-selectin","volume":"119","author":"Poppe","year":"1997","journal-title":"J\u00a0Am Chem Soc"},{"issue":"17","key":"10.1016\/j.bvth.2024.100015_bib31","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1021\/acs.jcim.3c00704","article-title":"How E-, L-, and P-selectins bind to sLex and PSGL-1: a quantification of critical residue interactions","volume":"63","author":"Sladek","year":"2023","journal-title":"J Chem Inf Model"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/bloodadvances.2022008209","article-title":"Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease","volume":"7","author":"Kanter","year":"2023","journal-title":"Blood Adv"},{"issue":"24","key":"10.1016\/j.bvth.2024.100015_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1182\/blood.2023021220","article-title":"The challenge of clinical end points in sickle cell disease","volume":"142","author":"Ataga","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.25308","article-title":"Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: a SUSTAIN study analysis","volume":"94","author":"Kutlar","year":"2019","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.bvth.2024.100015_bib36","article-title":"International differences in outpatient pain management: a survey of sickle cell disease","volume":"8","author":"El-Amin","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5455\/msm.2012.24.112-120","article-title":"Comparisons of health care systems in the United States, Germany and Canada","volume":"24","author":"Ridic","year":"2012","journal-title":"Mater Sociomed"},{"issue":"suppl 3","key":"10.1016\/j.bvth.2024.100015_bib38","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/1475-6773.13708","article-title":"International comparison of health spending and utilization among people with complex multimorbidity","volume":"56","author":"Figueroa","year":"2021","journal-title":"Health Serv Res"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib39","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"139","author":"Stam","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/FJC.0000000000000233","article-title":"First-in-man study with inclacumab, a human monoclonal antibody against P-selectin","volume":"65","author":"Schmitt","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"20","key":"10.1016\/j.bvth.2024.100015_bib41","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jacc.2013.03.003","article-title":"Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial","volume":"61","author":"Tardif","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jacc.2015.10.071","article-title":"Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial","volume":"67","author":"St\u00e4hli","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bvth.2024.100015_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/417586","article-title":"Inhibition of P-selectin and PSGL-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib","volume":"2015","author":"Muz","year":"2015","journal-title":"BioMed Res Int"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/ni1456","article-title":"Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs","volume":"8","author":"Veerman","year":"2007","journal-title":"Nat Immunol"},{"issue":"50","key":"10.1016\/j.bvth.2024.100015_bib45","doi-asserted-by":"crossref","first-page":"51775","DOI":"10.1074\/jbc.M409868200","article-title":"Human P-selectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus","volume":"279","author":"Hirata","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib46","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1016\/j.apsb.2023.07.028","article-title":"A\u00a0non-human primate derived anti-P-selectin glycoprotein ligand-1 antibody curtails acute pancreatitis by alleviating the inflammatory responses","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"10.1016\/j.bvth.2024.100015_bib47","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.99.10.1363","article-title":"Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model","volume":"99","author":"Kumar","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2004.05.052","article-title":"Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography","volume":"44","author":"Hansen","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.bvth.2024.100015_bib49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/01.CIR.103.8.1128","article-title":"Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine","volume":"103","author":"Bienvenu","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0735-1097(03)81179-8","article-title":"Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: the RAPSODY trial","volume":"41","author":"Tanguay","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib51","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ahj.2006.04.020","article-title":"Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial","volume":"152","author":"Mertens","year":"2006","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib52","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1600-6143.2011.03441.x","article-title":"rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study","volume":"11","author":"Busuttil","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-0012.2010.01295.x","article-title":"YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study 1, 2, 3","volume":"25","author":"Osama Gaber","year":"2011","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib54","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.immuni.2016.05.011","article-title":"PSGL-1 is an immune checkpoint regulator that promotes T cell exhaustion","volume":"44","author":"Tinoco","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bvth.2024.100015_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869768","article-title":"PD-1 immune checkpoint blockade and PSGL-1 inhibition synergize to reinvigorate exhausted T cells","volume":"13","author":"Viramontes","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112436","article-title":"PSGL-1 attenuates early TCR signaling to suppress CD8(+) T cell progenitor differentiation and elicit terminal CD8(+) T cell exhaustion","volume":"42","author":"Hope","year":"2023","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/2326-6066.CIR-21-0690","article-title":"Targeting the PSGL-1 immune checkpoint promotes immunity to PD-1-resistant melanoma","volume":"10","author":"DeRogatis","year":"2022","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"10.1016\/j.bvth.2024.100015_bib58","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1158\/2767-9764.CRC-22-0513","article-title":"PSGL-1 blockade induces classical activation of human tumor-associated macrophages","volume":"3","author":"Kauffman","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.bvth.2024.100015_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/srep37953","article-title":"Soluble siglec-5 associates to PSGL-1 and displays anti-inflammatory activity","volume":"6","author":"Pepin","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/oli.1.1998.8.265","article-title":"Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion","volume":"8","author":"Jenison","year":"1998","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2010-05-285718","article-title":"Inhibition of cell adhesion by anti\u2013P-selectin aptamer: a new potential therapeutic agent for sickle cell disease","volume":"117","author":"Gutsaeva","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2013-5-4-34-43","article-title":"Aptamers: problems, solutions and prospects","volume":"5","author":"Lakhin","year":"2013","journal-title":"Acta Naturae"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.bvth.2024.100015_bib64","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/molecules25122835","article-title":"Selectins\u2014the two Dr. Jekyll and Mr. Hyde faces of adhesion molecules\u2014a review","volume":"25","author":"Tvaro\u0161ka","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib65","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1172\/JCI117066","article-title":"Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats","volume":"93","author":"Buerke","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/ajrccm.162.1.9712142","article-title":"The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy","volume":"162","author":"Kerr","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib67","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1517\/13543771003767468","article-title":"Selectin inhibitors: a patent review","volume":"20","author":"Bedard","year":"2010","journal-title":"Expert Opin Ther Pat"},{"issue":"10","key":"10.1016\/j.bvth.2024.100015_bib68","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-12-260513","article-title":"GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice","volume":"116","author":"Chang","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.bvth.2024.100015_bib69","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.2022015797","article-title":"A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis","volume":"141","author":"Dampier","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41408-019-0227-3","article-title":"Inhibition of E-selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy","volume":"9","author":"Muz","year":"2019","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.bvth.2024.100015_bib72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00403-005-0626-0","article-title":"Pan-selectin antagonism improves psoriasis manifestation in mice and man","volume":"297","author":"Friedrich","year":"2006","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pupt.2012.12.003","article-title":"Inhaled pan-selectin antagonist bimosiamose attenuates airway inflammation in COPD","volume":"26","author":"Watz","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pupt.2005.07.004","article-title":"Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial","volume":"19","author":"Beeh","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.bvth.2024.100015_bib75","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm9704917","article-title":"Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-Bis[3-(3-carboxymethylphenyl)-4-(2-\u03b1-d-mannopyranosyloxy)phenyl]hexane (TBC1269)","volume":"41","author":"Kogan","year":"1998","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.bvth.2024.100015_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/676731","article-title":"Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins","volume":"2012","author":"Bendas","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.ATV.0000137189.22999.3f","article-title":"Heparin-binding domains in vascular biology","volume":"24","author":"Munoz","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib78","first-page":"109","article-title":"Heparan sulfate-protein interactions\u2013a concept for drug design?","volume":"98","author":"Lindahl","year":"2007","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2024.100015_bib79","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bcp.2006.05.006","article-title":"The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity","volume":"72","author":"Fritzsche","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI0214996","article-title":"Heparin\u2019s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L-and P-selectins","volume":"110","author":"Wang","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"28","key":"10.1016\/j.bvth.2024.100015_bib81","doi-asserted-by":"crossref","first-page":"29202","DOI":"10.1074\/jbc.M312951200","article-title":"Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions","volume":"279","author":"Wei","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2005.01.034","article-title":"Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells","volume":"229","author":"Wei","year":"2005","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib83","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bjh.14303","article-title":"Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion","volume":"175","author":"Telen","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib84","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood.V82.11.3253.3253","article-title":"Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation","volume":"82","author":"Nelson","year":"1993","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.bvth.2024.100015_bib85","article-title":"A\u00a0novel galactoxylan derived from viola diffusa alleviates LPS-induced acute lung injury via antagonizing P-selectin-mediated adhesion function","volume":"242","author":"Dai","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib86","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13880209.2014.919597","article-title":"Inhibitory function of P-selectin-mediated leukocyte adhesion by the polysaccharides from Sanguisorba officinalis","volume":"53","author":"Tong","year":"2015","journal-title":"Pharm Biol"},{"issue":"7","key":"10.1016\/j.bvth.2024.100015_bib87","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/sj.bjp.0704397","article-title":"Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis","volume":"134","author":"Ikegami-Kuzuhara","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/jsre.2001.6258","article-title":"A\u00a0novel selectin blocker alleviates oxidative stress of lung reperfusion injury","volume":"101","author":"Yoshimura","year":"2001","journal-title":"J\u00a0Surg Res"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib89","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1038\/ncomms7387","article-title":"Glycopeptide analogues of PSGL-1 inhibit P-selectin in\u00a0vitro and in\u00a0vivo","volume":"6","author":"Krishnamurthy","year":"2015","journal-title":"Nat Commun"},{"issue":"25","key":"10.1016\/j.bvth.2024.100015_bib90","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1021\/jacs.4c05090","volume":"146","author":"Dhakal","year":"2024","journal-title":"J Am Chem Soc"},{"issue":"13","key":"10.1016\/j.bvth.2024.100015_bib91","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.2020009428","article-title":"A\u00a0PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis","volume":"138","author":"Wong","year":"2021","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bvth.2024.100015_bib92","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1016\/S0021-9258(17)36574-2","article-title":"Inositol polyanions. Noncarbohydrate inhibitors of L- and P-selectin that block inflammation","volume":"269","author":"Cecconi","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib93","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0968-0896(01)00023-2","article-title":"Studies on selectin blocker. 9. SARs of non-sugar selectin blocker against E-P-L-selectin bindings","volume":"9","author":"Moriyama","year":"2001","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"10.1016\/j.bvth.2024.100015_bib94","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/jm000508c","article-title":"Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity","volume":"44","author":"Slee","year":"2001","journal-title":"J\u00a0Med Chem"},{"issue":"9","key":"10.1016\/j.bvth.2024.100015_bib95","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1358\/dof.2002.027.09.694988","article-title":"KF38789: treatment of ischemia reperfusion injury, P-selectin inhibitor","volume":"27","author":"Miki","year":"2002","journal-title":"Drugs Future"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib96","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/PL00000232","article-title":"Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789","volume":"50","author":"Ohta","year":"2001","journal-title":"Inflamm Res"},{"issue":"6","key":"10.1016\/j.bvth.2024.100015_bib97","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/jm060536g","article-title":"Rational design of novel, potent small molecule pan-selectin antagonists","volume":"50","author":"Kranich","year":"2007","journal-title":"J\u00a0Med Chem"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/jm0602256","article-title":"Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists","volume":"50","author":"Kaila","year":"2007","journal-title":"J\u00a0Med Chem"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/jm060631p","article-title":"2-(4-Chlorobenzyl)-3-hydroxy-7, 8, 9, 10-tetrahydrobenzo [H] quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists","volume":"50","author":"Kaila","year":"2007","journal-title":"J\u00a0Med Chem"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jvs.2006.05.021","article-title":"Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis","volume":"44","author":"Myers","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib101","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.107.128124","article-title":"Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7, 8, 9, 10-tetrahydrobenzo [h] quinoline-4-carboxylic acid] in\u00a0vitro and in rodent models of vascular inflammation and thrombosis","volume":"324","author":"Bedard","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jvs.2005.04.045","article-title":"Decreased venous thrombosis with an oral inhibitor of P selectin","volume":"42","author":"Myers","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"issue":"3","key":"10.1016\/j.bvth.2024.100015_bib103","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1160\/TH06-11-0658","article-title":"Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation","volume":"97","author":"Myers","year":"2007","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bvth.2024.100015_bib104","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1538-7836.2009.03587.x","article-title":"P-selectin antagonism reduces thrombus formation in humans","volume":"7","author":"Chelliah","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib105","article-title":"Effect of PSI-697, a novel P-selectin inhibitor, on platelet\u2013monocyte aggregate formation in humans","volume":"2","author":"Japp","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.bvth.2024.100015_bib106","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1160\/TH07-10-0608","article-title":"Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation","volume":"99","author":"Meier","year":"2008","journal-title":"Thromb Haemost"},{"issue":"16","key":"10.1016\/j.bvth.2024.100015_bib107","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/jm9013696","article-title":"Discovery of 2-[1-(4-chlorophenyl) cyclopropyl]-3-hydroxy-8-(trifluoromethyl) quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury","volume":"53","author":"Huang","year":"2010","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.bvth.2024.100015_bib108","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.2147\/IJN.S316863","article-title":"Nanoparticles of a new small-molecule P-selectin inhibitor attenuate thrombosis, inflammation, and tumor growth in two animal models","volume":"16","author":"Feng","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.bvth.2024.100015_bib109","article-title":"Amino acid modified R, R-heptacyclic carboxylic acid, synthesis, activity and application thereof","author":"Zhao","year":"2023","journal-title":"Chinese patent application"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087026","article-title":"The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib111","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bjh.19111","article-title":"Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease","volume":"204","author":"Allali","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bvth.2024.100015_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114323","article-title":"QiShen YiQi and its components attenuate acute thromboembolic stroke and carotid thrombosis by inhibition of CD62P\/PSGL-1-mediated platelet-leukocyte aggregate formation","volume":"160","author":"Yu","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.bvth.2024.100015_bib113","article-title":"reduces atherogenesis and vascular inflammation in ApoE\u2212\/\u2212 mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bvth.2024.100015_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apsb.2023.09.014","article-title":"Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba","volume":"14","author":"Ye","year":"2024","journal-title":"Acta Pharm Sin B"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327224000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327224000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:30:37Z","timestamp":1755999037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327224000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2950327224000159"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2024.100015","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the P-selectin\/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2024.100015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100015"}}